18097-Gastric Cancer-NA-138

Gastric Cancer

A Phase 3, randomized, double-blind clinical study of pembrolizumab (MK-3475) plus chemotherapy versus placebo plus chemotherapy as first-line treatment in participants with HER2 negative, previously untreated, unresectable or metastatic gastric or gastroesophageal junction adenocarcinoma (KEYNOTE-859)

  • Details

ClinicalTrials.gov ID: NCT03675737
Diagnosis Type: NA
USOR Number:

  • Address

6545 France Avenue, Suite 210
Edina, MN 55435
P: (952) 928-2900

Search by practice name, trial titles, indicators and specific disease types.

Find a Location

With more than 2,500 physicians and over 600 treatment locations across the country, the advanced cancer care you need may be available right in your local community from a practice in The US Oncology Network. Search to see if there is a center near you.